Skip to main content

Day: December 28, 2023

MedBright AI Announces Closing of Investment in Limmi Healthcare AI Platform

VANCOUVER, British Columbia, Dec. 28, 2023 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that further to its press releases dated September 8, 2023 and October 17, 2023, Vinergy Acquisition Corp., a wholly owned US subsidiary of MedBright (“MB Acquisition Co.”), has issued 350 common shares of MB Acquisition Co. (the “MBAC Shares”) to Mentorhead Incorporated, a Delaware corporation, dba Limmi (“Limmi”)‎ pursuant to the intellectual property license and option agreement dated October 16, 2023, as amended and restated December 20, 2023 (the “IP License and Option Agreement”). Pursuant to the IP License and Option Agreement, Limmi granted to Vinergy Licensing Corp., a wholly owned US subsidiary of MedBright (the “MB Licensing Co.”), certain rights to...

Continue reading

Capital Power completes acquisition of 50.15% interest in the Frederickson 1 Generating Station

EDMONTON, Alberta, Dec. 28, 2023 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) (“Capital Power”) successfully completed the acquisition of a 50.15% interest in the Frederickson 1 Generating Station (“Frederickson 1” or the “Facility”), a 265-megawatt (MW) natural gas-fired combined-cycle generation facility in Pierce County, Washington. The acquisition was previously announced on October 10, 2023. The facility was acquired from Atlantic Power & Utilities for US$97.5 million, subject to working capital adjustments. Capital Power financed the transaction using cash on hand and its credit facilities. The other 49.85% interest in the Facility is owned by Puget Sound Energy (“PSE”). As part of the ownership agreement with PSE, Capital Power will operate and maintain the facility and will receive an annual management fee...

Continue reading

Healthy Extracts Prepares for NYSE American Listing with Reverse Stock Split

LAS VEGAS, Dec. 28, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX, HYEXD), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, will effect a 1-for-120 reverse split of its common stock, effective at the opening of the market tomorrow, Friday, December 29, 2023.    The reverse stock split will be implemented in connection with the company’s intention to uplist the company’s common stock to the NYSE American. The reverse split is intended to fulfill the stock price requirements for a listing on the NYSE American stock exchange, which requires that the company’s common stock be priced at $3.00 or higher at the time of listing. The company is taking steps to satisfy...

Continue reading

Kadant to Acquire Key Knife, Inc.

WESTFORD, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) has entered into a definitive agreement to acquire Key Knife, Inc. and certain of its affiliates (“Key Knife”) for approximately $156 million in cash, subject to certain customary adjustments. The acquisition is expected to close in early January 2024, subject to the satisfaction of customary closing conditions, and will be financed primarily through borrowings under Kadant’s revolving credit facility. Founded in 1986, Key Knife is a global supplier of engineered knife systems for custom chipping, planing, and flaking solutions for wood product industries. Its products enable wood processing mills to improve fiber recovery, product quality, and maximize production while lowering operating costs. The company is headquartered in Tualatin, Oregon with 141 employees...

Continue reading

Results of Operations for the Three Months Ended September 30, 2023 – American Overseas Group Limited Announces Net Income Of $4.3 Million For the Three Months September 30, 2023

HAMILTON, Bermuda, Dec. 28, 2023 (GLOBE NEWSWIRE) — American Overseas Group Limited BSX: AORE.BH) (Pink Sheets: AOREF.PK) (“AOG” or the “Company”) today reported consolidated net income available to common shareholders of $4.3 million, or $91.11 per diluted share, for the three months ended September 30, 2023. This compares to consolidated net loss available to common shareholders of $0.4 million, or $9.42 per diluted share, for the three months ended September 30, 2022. Book value per weighted share at September 30, 2023 was $776.61, a slight decrease from the book value per weighted share of $780.66 at September 30, 2022. For the three months ended September 30, 2023, net earned property and casualty premiums increased $3.2 million from $4.8 million a year ago to $8.0 million.    Quarter to Date fee income increased $1.5 million...

Continue reading

HPQ Incentive Stock Option Distribution

MONTREAL, Dec. 28, 2023 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering processes for silica and silicon material manufacturing announces that on December 28, 2023, HPQ Board of Directors has granted the following incentive stock options under the company’s 2021 Stock Option Plan to directors, officers, employees, and consultants of the company entitling the option holders to acquire an aggregate of 9,800,000 common shares of the company. These options are exercisable at a price of $0.215 per share and will expire on December 28th, 2028. Each share issued pursuant to those grants will have a mandatory four (4) months and one (1) day holding period from the date of the grant of the options. About HPQ Silicon HPQ Silicon...

Continue reading

Dundee Corporation Announces Results of Substantial Issuer Bid for Its Series 3 Preferred Shares

TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A, DC.PR.B and DC.PR.D) (“Dundee” or the “Corporation”) announced today the results of its substantial issuer bid (the “Offer”) to purchase for cancellation from the holders thereof who chose to participate up to 975,610 of its issued and outstanding Cumulative Floating Rate First Preference Shares, Series 3 in the capital of the Corporation (the “Series 3 Shares”) at a purchase price of C$20.50 per Series 3 Share, for a maximum aggregate purchase price of C$20,000,005. The Offer expired at 11:59 p.m. (Toronto time) on December 27, 2023. Based on the report of Computershare Investor Services Inc., as depositary for the Offer (the “Depositary”), 914,040 Series 3 Shares were tendered to the Offer. In accordance with the terms and conditions of the Offer and based...

Continue reading

Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas

  Regulated information – Inside informationNo bankruptcy filing Significant reduction in Working Capital costs Atlas commits to fund Oxurion’s Working Capital costs (including the Preclinical GA Program) through 2024 using the existing Atlas Funding Program, under the conditions as set out below Intent to put in place Debt Restructuring plan Two new independent directors have been co-opted to the Board, and a new CEO/CFO, who will also act as an executive board member, have been appointed upon proposal of AtlasLeuven, BELGIUM – December 28, 2023 – 9:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announced today it has avoided bankruptcy by entering into a binding letter of intent (LOI) with Atlas Special Opportunities LLC (Atlas) and an addendum to the existing subscription...

Continue reading

Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise

CHESTERBROOK, Pa., Dec. 28, 2023 (GLOBE NEWSWIRE) — Trevena, Inc. (“Trevena” or the “Company”) (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it has closed its previously announced offering for the issuance and sale of 2,779,906 shares of common stock (or pre-funded warrants in lieu thereof) of Trevena and warrants to purchase up to an aggregate of 2,779,906 shares of common stock of Trevena, at a purchase price of $0.70 per share (or pre-funded warrant in lieu thereof) and associated warrant in a private placement, for gross proceeds to the Company of approximately $1.946 million (the “private placement”). Pursuant to a previously announced definitive agreement with respect to the immediate...

Continue reading

GN Store Nord announces change to the Board of Directors

Board member Ronica Wang has decided to step down from the Board of Directors of GN Store Nord A/S. Consequently, GN’s Board of Directors as of today consists of Jukka Pekka Pertola (Chair), Klaus Holse (Deputy chair), Anette Weber, Hélène Barnekow, and members elected by the employees: Leo Larsen, Cathrin Inge Hansen, and Claus Holmbeck-Madsen. For further information, please contact: Investor RelationsAnne Sofie Staunsbæk Veyhe +45 45 75 85 06Rune Sandager +45 45 75 92 57 Media Relations Steen Frentz Laursen +45 20 65 34 20 About GN GN facilitates communication between people through intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our passion for innovation, we leverage technologies to deliver unique user experiences that bring people closer through the power of sound and vision. GN was founded...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.